HIV Prevention Trials Network

HIV Prevention Trials Network

Company type	Nonprofit organization
Industry	HIV Prevention Research
Headquarters	Durham, North Carolina , United States
Key people	Myron Cohen, MD, HPTN Principal Investigator Wafaa El-Sadr MD, MPH, MPA, HPTN Principal Investigator
Website	www.hptn.org

The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. HPTN studies evaluate new HIV prevention interventions and strategies in populations and geographical regions that bear a disproportionate burden of infection. The HPTN is committed to the highest ethical standards for its clinical trials and recognizes the importance of community engagement in all phases of the research process.

The HPTN was established in 2000, building on the work of the HIV Network for Prevention Trials (HIVNET). HPTN’s Leadership and Operations Center (LOC) is based at FHI 360, Durham, NC.^[1] Its Laboratory Center (LC) Archived 2018-10-03 at the Wayback Machine is at Johns Hopkins University, Baltimore, MD and Statistical and Data Management Center (SDMC) is housed within the Statistical Center for HIV/AIDS Research and Prevention (SCHARP) at the Fred Hutchinson Cancer Research Center in Seattle, Washington. The HPTN Modelling Centre, part of the SDMC, is a collaboration between the Department of Infectious Diseases Epidemiology at Imperial College London, UK, and SCHARP.

The U.S. National Institute of Allergy and Infectious Diseases, the U.S. National Institute of Mental Health, Office of The Director, the U.S. National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, all part of the U.S. National Institutes of Health, co-fund the HPTN.